Quick Heal Technologies Limited (NSE: QUICKHEAL) convened a board meeting on June 18, 2026, with the outcome communicated to the NSE at 13:33 IST. The announcement does not yet disclose whether a dividend has been recommended for FY2025-26, making it a closely watched development for income-seeking shareholders given the company's historically inconsistent payout record.

Dividend History: A Declining and Irregular Trend

Quick Heal's dividend distribution over the past decade reveals a pattern that has grown increasingly irregular. The company's payout history on a per-share basis is as follows:

Notably, there is no dividend on record for FY2020-21, FY2022-23, or FY2024-25 based on available exchange disclosures. The most recent payout of ₹3.00 per share in April 2024 marked a 33.3% decline from the ₹4.50 per share declared in May 2022. The absence of a declared dividend in the intervening FY2022-23 period further underscores the lack of a consistent annual payout policy.

Dividend Yield: Limited Visibility Without Current Price Data

Exchange trade data for QUICKHEAL was not available at the time of this report. Based on the last declared dividend of ₹3.00 per share for FY2023-24, the dividend yield would be calculated against the prevailing market price on the record date. Investors tracking this metric should note that the stock's 52-week range and current trading price are required for a precise yield computation, and those figures were not available from the current data feed. Once the June 18, 2026 board outcome is formally disclosed, any new dividend recommendation will allow a more current yield assessment.

Company Background

Quick Heal Technologies is one of India's established cybersecurity software companies, offering endpoint security, enterprise solutions, and consumer antivirus products under the Quick Heal and Seqrite brands. Listed on both NSE and BSE, the company carries the ISIN INE306L01010. The cybersecurity sector in India has seen increased institutional interest amid rising enterprise digitisation, though smaller domestic players face competitive pressure from global vendors.

What the Dividend Trend Signals for Investors

The inconsistency in Quick Heal's dividend declarations, with gaps in FY2020-21, FY2022-23, and FY2024-25, suggests the board does not follow a fixed dividend policy tied to annual earnings. Payouts appear discretionary and linked to specific financial year performance. The step-down from ₹4.50 in FY2021-22 to ₹3.00 in FY2023-24 indicates either moderated earnings or a preference to retain capital. Investors relying on this stock for regular income should treat any dividend announcement as event-driven rather than predictable. The outcome of the June 18, 2026 board meeting, once fully disclosed on the NSE platform, will clarify whether a dividend has been recommended for FY2025-26 and whether the company is reversing the recent downward trend in per-share payouts.